Morning Briefing
Summaries of health policy coverage from major news organizations
Sanofi To Cut Cost Of Colon Cancer Drug In Half After Cancer Center Denial
Drugmaker Sanofi will cut the price of a colon cancer drug nearly in half after a large cancer center said it wouldn't use the drug over cost concerns.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
